Symposium C2
Continuous Manufacturing – the “holy grail” for pharmaceutical products?

Tuesday 23 May 2017
Stockholmsmässan : K11


As conventional large batch manufacturing is increasingly regarded as inflexible and unsustainable, the continuous manufacturing concept has planted a new hope in the pharmaceutical industry to improve process efficiency and product quality. This session will highlight the various elements necessary for successful implementation of continuous manufacturing predicted to resulting in reduced production time and a shorter time to market.

Chair: Paul Wan Sia Heng, National University of Singapore, Singapore


08:00 – 08:35 Continuous manufacturing: the future in pharmaceutical solid dosage form manufacturing
Paul Wan Sia Heng, National University of Singapore, Singaporw

08:35 – 09:10 Making the business case for continuous manufacturing in the pharmaceutical industry
Tomás S.Harrington, University of Cambridge, UK

09:10 – 09:30 BREAK

09:30 – 10:05 Developing the end-to-end supply chain
Craig Johnston, University of Strathclyde, UK

10:05 – 10:40 On-demand continuous-flow production of pharmaceuticals in a compact, reconfigurable system
Andrea Adamo, MIT, USA

10:40 – 11:00 Panel discussion
Paul Wan Sia Heng, National University of Singapore, Singapore